MAY 19, 2017 05:16 PM PDT

C. auris Superbug Seen in More Patients Across US

WRITTEN BY: Carmen Leitch

The Centers for Disease Control (CDC) issued an alert in June 2016 about Candida auris; later that summer seven cases were described. The CDC has now reported 122 new cases of infection resulting from the C. auris bacterium. It’s considered a superbug because it’s very difficult to treat, and is primarily a threat to those faced with lengthy hospital stays.

 

The infections are typically occurring in older, chronically ill people in healthcare facilities and the CDC is focusing efforts on preventing transmission there. The infections have happened in three principle areas: Illinois, New Jersey and New York.

C. auris was first identified in Japan, and has managed to spread around the world in only about eight years. Scientists are concerned about it not only because it is often resistant to so many drugs like fluconazole, amphotericin B, and even echinocandins; it also has a very high mortality rate.

“This emerging fungal species has started to infect patients globally, causing invasive infections that are associated with a high death rate,” commented Mahmoud Ghannoum, PhD, MBA, FIDSA, Professor and Director of the Center for Medical Mycology at the Department of Dermatology at Case Western Reserve School of Medicine, and University Hospitals Cleveland Medical Center. “It is multidrug-resistant, and some strains isolated from patients are resistant to all commercially available antifungal drugs. Multidrug-resistance used to be reported for bacteria only, and now we must add fungi to the list.”

Related: Understanding the Dissemination of Antibiotic Resistance Genes

Ghannoum has led a study of 16 strains of C. auris, and is studying the effects of an investigational drug on the infection.

“Understanding the virulence of C. auris and showing that the investigational drug is effective may lead to the development of new medications to combat this emerging health threat,” said Ghannoum. “Eradication of Candida auris from hospitals is very difficult and in some cases has led to closing hospital wards.”

The bacterium lurks on catheters, and those staying in the hospital for long periods of time are most at risk.


Sources: STAT News, Case Western Reserve University, CDC, Medscape

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 30, 2018
Drug Discovery
SEP 30, 2018
Researchers Re-classify the 'Magic Mushroom' Drug
Researchers at John Hopkins have evaluated the safety and efficacy of compound, psilocybin, found in hallucinogenic mushrooms. They suggested that if evalu...
NOV 06, 2018
Microbiology
NOV 06, 2018
A Move to the US Significantly Changes a Person's Microbiome
A move to the United States is extremely disruptive to health of a person's gut microbial community, researchers have found....
NOV 16, 2018
Microbiology
NOV 16, 2018
Testing the Impact of a Low-gluten Diet on Healthy People
Gluten-free diets have exploded in popularity in recent years, even for people who don't have documented food allergies....
NOV 26, 2018
Health & Medicine
NOV 26, 2018
The Fight Bite
  Human bite wounds are a common source of polymicrobial infections accounting for many emergency room visits. One bacteria, Eikenella corrodens, ...
NOV 25, 2018
Microbiology
NOV 25, 2018
Researchers Learn How Hantavirus Infects Cells
First identified in 1993, hantavirus infections can cause dangerous and potentially deadly respiratory infections....
NOV 29, 2018
Microbiology
NOV 29, 2018
Bacteria may Explain the Symbiotic Relationship of Anemones & Clownfish
Sea anemones normally kill and eat fish. But clownfish can nestle into anemones without getting stung....
Loading Comments...